Indeed, in patients with nonsmall cell lung cancer (NSCLC), high serum chemerin levels were shown to be associated with shorter overall survival [22], whereas high chemerin expression in tumor as assessed by immunohistology was found to be associated with better survival [23]. The gene discussed is RARRES2; the disease is lung cancer.